Ad
Thursday, 24 May 2018
Global group taps U.S. biotechs to speed work on Nipah vaccine
LONDON (Reuters) - A global coalition set up a year ago to fight epidemics has struck a $25 million deal with two U.S. biotech companies to accelerate work on a vaccine against the brain-damaging Nipah virus that has killed at least 11 people in India.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment